Selective inhibition of BET bromodomains-Reference-Cited by-同舟云学术

Selective inhibition of BET bromodomains

Published:2010-09-24 Issue:7327 Volume:468 Page:1067-1073
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Filippakopoulos Panagis,Qi Jun,Picaud Sarah,Shen Yao,Smith William B.,Fedorov Oleg,Morse Elizabeth M.,Keates Tracey,Hickman Tyler T.,Felletar Ildiko,Philpott Martin,Munro Shonagh,McKeown Michael R.,Wang Yuchuan,Christie Amanda L.,West Nathan,Cameron Michael J.,Schwartz Brian,Heightman Tom D.,La Thangue Nicholas,French Christopher A.,Wiest Olaf,Kung Andrew L.,Knapp Stefan,Bradner James E.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09504.pdf

Reference43 articles.

1. Ptashne, M. Binding reactions: epigenetic switches, signal transduction and cancer. Curr. Biol. 19, R234–R241 (2009)

2. Schreiber, S. L. & Bernstein, B. E. Signaling network model of chromatin. Cell 111, 771–778 (2002)

3. Marushige, K. Activation of chromatin by acetylation of histone side chains. Proc. Natl Acad. Sci. USA 73, 3937–3941 (1976)

4. Dey, A., Nishiyama, A., Karpova, T., McNally, J. & Ozato, K. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol. Biol. Cell 20, 4899–4909 (2009)

5. Owen, D. J. et al. The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J. 19, 6141–6149 (2000)

Cited by 3468 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of PES1 in disease: A promising therapeutic target?;Gene;2025-01

2. Current concepts in the epigenetic regulation of cardiac fibrosis;Cardiovascular Pathology;2024-11

3. Targeting breast cancer with rationally designed quinazolines: A scaffold hopping strategy;Journal of Molecular Structure;2024-11

4. BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer;Pharmacological Research;2024-10

5. Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy;Bioorganic & Medicinal Chemistry;2024-10